Zimmer Biomet (NYSE: ZBH) announced today that the FDA granted 510(k) clearance for its Rosa Knee surgical robot with ...
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of ROSA® Knee with OptimiZe™, an enhanced ...
ROSA ® Knee with OptimiZe Offers Personalized Surgical Planning and Drives Confidence in Delivering Accurate and Reproducible Outcomes1 WARSAW, Ind., Nov. 14, 2025 /PRNewswire/ -- Zimmer ...
Zimmer Biomet’s Rosa knee robot was with OptimiZe earned FDA 510(k) clearance, according to a Nov. 14 news release. OptiMize is an enhanced version of the Rosa knee system that is designed fora more ...
Deloitte asks toss Zimmer Biomet lawsuit, citing lack of proper breach notice and non-consumer contract issues in $172 million dispute.
Zacks Investment Research on MSN
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback